Ledger.Open graph →
SEC Form D · filed August 24, 2020

Clene Nanomedicine, Inc

Offering
$46.2M
Sold
$42.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SALT LAKE CITY, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Hayfin HF GP LLC · London, United KingdomDirectorHoward Rowe · London, United KingdomDirectorRob Etherington · Salt Lake City, UTExec · DirectorJoshua P. Tatum · Peachtree Corners, GADirectorArie Abecassis · White Plains, NYDirectorT.J. Stouder · Fanwood, NJDirectorDavid Rushford · London, United KingdomDirectorMark Tognolini · London, United KingdomDirectorChad Young · Salt Lake City, UTDirectorDavid Lisonbee · Salt Lake City, UTDirectorTim Flynn · London, United KingdomDirectorYoshiyuki Nakamura · Fletcher, NCExec · DirectorHayfin Management Limited · London, United KingdomDirectorNathaniel Weiss · Cambridge, MADirectorWilliam Fleming · Fanwood, NJDirectorAlison Mosca · Salt Lake City, UTDirectorStephanie C. Arkof · Encino, CADirectorJeremy Doo · Wilton, CTDirectorReed Wilcox · Salt Lake City, UTDirectorJohn Stevens · Salt Lake City, UTDirectorJ. P. Bayliss · Ridgefield, CTExec · DirectorDoug Kimmel · Fanwood, NJDirectorRobert Gay · Salt Lake City, UTDirectorShalom Jacobovitz · Salt Lake City, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗